BioClinica releases MCC Clinical Trial Performance Metrics reporting solution

BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, is the first clinical technology provider to offer a reporting solution that incorporates the industry-standard performance metrics for clinical trials as defined by the Metrics Champion Consortium (MCC).

“BioClinica is a vigorous supporter of standards initiatives such as the MCC and CDISC. Standards help the industry drive efficiency and facilitate transparency of the data associated with clinical trials”

BioClinica is a Corporate Sponsor of the Metrics Champion Consortium (MCC), an open, collaborative organization dedicated to fostering the development of performance metrics for both Sponsors and Service Providers in support of an improved drug development process. BioClinica has supported the definition of both Imaging and Clinical Trials metrics through its participation in the MCC. "BioClinica is a vigorous supporter of standards initiatives such as the MCC and CDISC. Standards help the industry drive efficiency and facilitate transparency of the data associated with clinical trials," said Peter Benton, President of BioClinica's eClinical Division.

The Clinical Trial Performance Metrics allow trial sponsors and CROs to share a common view of clinical trial performance across studies. "As we approach the release of MCC Clinical Trial Performance Metrics version 1.0, we are pleased by the enthusiasm of MCC members preparing to be able to track and report the metrics. The BioClinica reporting system is a good example of how MCC members are helping us move forward with fulfilling our mission of providing the platforms, tools and shared learning opportunities that encourage performance improvement, effectiveness, efficiency and appropriate levels of control in the drug development process," states Guy Mascaro, President of the MCC.

The BioClinica Performance Dashboard and portals provide MCC-Based Metrics/Scorecards such as:

• Patient Retention
• Generation of Query to update of Query Response
• CRF Pages Received/scanned to Data Entry Complete
• Site Productivity
• % subjects enrolled, and
• Site Activation to First Patient First Visit

The MCC Clinical Trial Performance Metrics (beta version), was released for industry review in April. BioClinica will demonstrate the first instance of MCC Clinical Trial Performance metrics that have been programmatically generated across studies and from different clinical systems. The reports deliver data on study progress with interactive functionality that allows users to drill down on various aspects of tracking performance. This reporting solution is part of the BioClinica Integrated Operational Platform demonstration at the 46^th DIA Annual Meeting in Washington, DC at exhibits #111 and #2005 from June 14 - 16.